Lorundrostat
A mineralocorticoid receptor antagonist
Lorundrostat is a pharmaceutical compound that functions as a mineralocorticoid receptor antagonist. It is primarily being investigated for its potential use in the treatment of conditions such as hypertension and heart failure.
Mechanism of Action[edit | edit source]
Lorundrostat works by inhibiting the action of the mineralocorticoid receptor, which is a type of nuclear receptor that binds to aldosterone, a hormone involved in the regulation of sodium and water balance in the body. By blocking this receptor, lorundrostat reduces the effects of aldosterone, leading to decreased sodium reabsorption and increased excretion of sodium and water, which can help lower blood pressure and reduce fluid overload in conditions like heart failure.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of lorundrostat includes its absorption, distribution, metabolism, and excretion. After oral administration, lorundrostat is absorbed into the bloodstream, where it exerts its effects on the mineralocorticoid receptors. The metabolism of lorundrostat involves hepatic pathways, and it is eventually excreted through renal and fecal routes.
Clinical Development[edit | edit source]
Lorundrostat is currently undergoing clinical trials to evaluate its efficacy and safety in patients with hypertension and heart failure. These trials aim to determine the optimal dosing regimen and to assess the potential side effects associated with its use.
Potential Benefits[edit | edit source]
The use of lorundrostat in clinical practice could offer several benefits, particularly for patients who are resistant to conventional antihypertensive therapies. By providing an alternative mechanism of action, lorundrostat may help achieve better blood pressure control and improve outcomes in patients with heart failure.
Side Effects[edit | edit source]
As with any medication, lorundrostat may cause side effects. Commonly reported side effects include dizziness, fatigue, and electrolyte imbalances such as hyperkalemia. Monitoring of blood pressure and electrolyte levels is recommended during treatment.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
